{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:06:18Z","timestamp":1781949978826,"version":"3.54.5"},"reference-count":23,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Background: Elevated serum levels of sFlt-1 were found in non-pregnant severe COVID-19 patients. The aim was to investigate sFlt-1\/PlGF ratio as a predictor of severe disease and adverse outcome in pregnant women with COVID-19. Methods: A single-center case-control study was conducted in pregnant women with SARS-CoV-2 infection. SARS-CoV-2-negative pregnant women served as controls. Serum sFlt-1\/PlGF ratio was assessed. The primary outcome was severe COVID-19 and the secondary outcome comprised adverse outcomes including severe COVID-19, intensive care unit admission, maternal multiple organ failure, preterm delivery, fetal demise, preeclampsia or hypertension diagnosed after COVID-19, maternal death. Results: 138 women with SARS-CoV-2 infection and 140 controls were included. sFlt-1\/PlGF ratio was higher in infected patients (11.2 vs. 24; p &lt; 0.01) and in women with severe disease (50.8 vs. 16.2; p &lt; 0.01). However, it was similar in women with adverse and non-adverse outcome (29.8 vs. 20; p = 0.2). The AUC of sFlt-1\/PlGF ratio was 0.66 (95% CI 0.56\u20130.76) for the prediction of severe COVID-19, and 0.72 (95% CI 0.63\u20130.79) for the prediction of adverse outcome. Conclusions: sFlt-1 and sFlt-1\/PlGF ratio are related to SARS-CoV-2 infection and the severity of COVID-19 during pregnancy. However, sFlt-1\/PlGF ratio is not a good predictor of severe COVID-19 or adverse outcome.<\/jats:p>","DOI":"10.3390\/ijerph192215054","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T02:27:34Z","timestamp":1668565654000},"page":"15054","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["sFlt-1\/PlGF Ratio Is Not a Good Predictor of Severe COVID-19 nor of Adverse Outcome in Pregnant Women with SARS-CoV-2 Infection\u2014A Case-Control Study"],"prefix":"10.3390","volume":"19","author":[{"given":"Ewa","family":"Malicka","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Szymusik","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-7561","authenticated-orcid":false,"given":"Beata","family":"Rebizant","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-4091","authenticated-orcid":false,"given":"Filip","family":"D\u0105browski","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-873X","authenticated-orcid":false,"given":"Robert","family":"Brawura-Biskupski-Samaha","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-273X","authenticated-orcid":false,"given":"Katarzyna","family":"Kosi\u0144ska-Kaczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"ref_1","first-page":"157","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Espino-Y-Sosa, S., Martinez-Portilla, R.J., Torres-Torres, J., Solis-Paredes, J.M., Estrada-Gutierrez, G., Hernandez-Pacheco, J.A., Espejel-Nu\u00f1ez, A., Mateu-Rogell, P., Juarez-Reyes, A., and Lopez-Ceh, F.E. (2021). Novel Ratio Soluble Fms-like Tyrosine Kinase-1\/Angiotensin-II (sFlt-1\/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19. Viruses, 13.","DOI":"10.3390\/v13101906"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/uog.23575","article-title":"Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: Propensity score matched analysis of a nationwide prospective cohort (COV19Mx)","volume":"57","author":"Sotiriadis","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajog.2021.08.054","article-title":"An update on COVID-19 and pregnancy","volume":"226","author":"Jamieson","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome","volume":"75","author":"Stepan","year":"2020","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1172\/JCI107462","article-title":"A study of angiotensin II pressor response throughout primigravid pregnancy","volume":"52","author":"Gant","year":"1973","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: New roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: The convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.preghy.2021.12.001","article-title":"sFlt-1\/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19","volume":"27","author":"Soldavini","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/cid\/ciaa1007","article-title":"Excess Soluble fms-like Tyrosine Kinase 1 Correlates with Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients","volume":"72","author":"Dupont","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"E188","DOI":"10.1002\/ajh.25882","article-title":"Increased sFLT-1\/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction","volume":"95","author":"Giardini","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Giardini, V., Ornaghi, S., Acampora, E., Vasarri, M.V., Arienti, F., Gambacorti-Passerini, C., Casati, M., Carrer, A., and Vergani, P. (2021). Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection. Viruses, 13.","DOI":"10.3390\/v13122377"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/uog.24798","article-title":"Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19","volume":"59","author":"Poon","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"894633","DOI":"10.3389\/fmed.2022.894633","article-title":"sFlt-1 Is an Independent Predictor of Adverse Maternal Outcomes in Women with SARS-CoV-2 Infection and Hypertensive Disorders of Pregnancy","volume":"9","year":"2022","journal-title":"Front. Med."},{"key":"ref_16","unstructured":"(2022, October 05). Clinical Spectrum of SARS-CoV-2 Infection, Available online: https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/clinical-spectrum\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score-development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5603\/AH.a2019.0011","article-title":"Management of hypertension in pregnancy\u2014Prevention, diagnosis, treatment and long-term prognosis. A position statement of the Polish Society of Hypertension, Polish Cardiac Society and Polish Society of Gynaecologists and Obstetricians","volume":"23","author":"Prejbisz","year":"2019","journal-title":"Arter. Hypertens."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"289.e1","DOI":"10.1016\/j.ajog.2021.05.014","article-title":"Preeclampsia and COVID-19: Results from the INTERCOVID prospective longitudinal study","volume":"225","author":"Papageorghiou","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2021.07.009","article-title":"SARS-CoV-2 infection during pregnancy and risk of preeclampsia: A systematic review and meta-analysis","volume":"226","author":"Romero","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ajog.2021.08.020","article-title":"SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: Evidence of a dose-response relationship supporting causality","volume":"225","author":"Lai","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2018.04.010","article-title":"Predictive value of sFlt-1, PlGF, sFlt-1\/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy","volume":"12","author":"Birdir","year":"2018","journal-title":"Pregnancy Hypertens."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/15054\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:19:04Z","timestamp":1760145544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/15054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":23,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijerph192215054"],"URL":"https:\/\/doi.org\/10.3390\/ijerph192215054","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]}}}